11 – 20 of 200
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation
(
- Contribution to journal › Article
-
Mark
Incidence of intracranial hemorrhagic complications after anterior circulation endovascular thrombectomy in relation to occlusion site : a nationwide observational register study
2023) In Journal of NeuroInterventional Surgery(
- Contribution to journal › Article
-
Mark
Delivery of acute ischaemic stroke treatments in the European region in 2019 and 2020
(
- Contribution to journal › Article
-
Mark
Effect of blood pressure-lowering agents on microvascular function in people with small vessel diseases (TREAT-SVDs) : a multicentre, open-label, randomised, crossover trial
(
- Contribution to journal › Article
-
Mark
Remote Ischemic Conditioning for Acute Stroke : The RESIST Randomized Clinical Trial
(
- Contribution to journal › Article
-
Mark
Multicentre, national, investigator-initiated, randomised, parallel-group, register-based superiority trial to compare extended ECG monitoring versus standard ECG monitoring in elderly patients with ischaemic stroke or transient ischaemic attack and the effect on stroke, death and intracerebral bleeding : the AF SPICE protocol
(
- Contribution to journal › Article
-
Mark
What is a Challenging Clot? : A DELPHI Consensus Statement from the CLOTS 7.0 Summit
(
- Contribution to journal › Article
-
Mark
Intracerebral hemorrhage and antithrombotic drugs - clinical aspects and prognostic outcomes
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Stroke Learning Health Systems : A Topical Narrative Review With Case Examples
(
- Contribution to journal › Scientific review
-
Mark
Dual antiplatelet Use for extended period taRgeted to AcuTe ischemic stroke with presumed atherosclerotic OrigiN (DURATION) trial : Rationale and design
(
- Contribution to journal › Article